These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30831242)

  • 21. Microglia disrupt mesolimbic reward circuitry in chronic pain.
    Taylor AM; Castonguay A; Taylor AJ; Murphy NP; Ghogha A; Cook C; Xue L; Olmstead MC; De Koninck Y; Evans CJ; Cahill CM
    J Neurosci; 2015 Jun; 35(22):8442-50. PubMed ID: 26041913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.
    O'Brien M; McDougall JJ
    Curr Opin Pharmacol; 2018 Jun; 40():104-109. PubMed ID: 29635215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Endocannabinoid System as a Therapeutic Target in Glaucoma.
    Cairns EA; Baldridge WH; Kelly ME
    Neural Plast; 2016; 2016():9364091. PubMed ID: 26881140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular interplay between endocannabinoid and neurotrophin signals in the nervous system and beyond.
    Keimpema E; Hökfelt T; Harkany T; Doherty P
    Eur J Neurosci; 2014 Feb; 39(3):334-43. PubMed ID: 24494674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolving role of the endocannabinoid system in gynaecological cancer.
    Ayakannu T; Taylor AH; Willets JM; Konje JC
    Hum Reprod Update; 2015; 21(4):517-35. PubMed ID: 25958409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoids, eating behaviour, and energy homeostasis.
    Romero-Zerbo SY; Bermúdez-Silva FJ
    Drug Test Anal; 2014; 6(1-2):52-8. PubMed ID: 24375977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling.
    Storozhuk MV; Zholos AV
    Curr Neuropharmacol; 2018 Jan; 16(2):137-150. PubMed ID: 28440188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the endocannabinoid system to treat anxiety-related disorders.
    Korem N; Zer-Aviv TM; Ganon-Elazar E; Abush H; Akirav I
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):193-202. PubMed ID: 26426887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of brain reward by the endocannabinoid system: a critical review of behavioral studies in animals.
    Vlachou S; Panagis G
    Curr Pharm Des; 2014; 20(13):2072-88. PubMed ID: 23829366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The endocannabinoid system role in the pathogenesis of obesity and depression].
    Zdanowicz A; Kaźmierczak W; Wierzbiński P
    Pol Merkur Lekarski; 2015 Jul; 39(229):61-6. PubMed ID: 26277182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An endocannabinoid hypothesis of drug reward and drug addiction.
    Onaivi ES
    Ann N Y Acad Sci; 2008 Oct; 1139():412-21. PubMed ID: 18991888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Brain in Energy Balance.
    Matafome P; Seiça R
    Adv Neurobiol; 2017; 19():33-48. PubMed ID: 28933060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system.
    Söderpalm B; Löf E; Ericson M
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S87-94. PubMed ID: 19434560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of endogenous cannabinoids in cerebral reward mechanisms].
    Wenger T; Fürst S
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):26-9. PubMed ID: 15125311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocannabinoids, exercise, pain, and a path to health with aging.
    Watkins BA
    Mol Aspects Med; 2018 Dec; 64():68-78. PubMed ID: 30290200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient changes in mesolimbic dopamine and their association with 'reward'.
    Wightman RM; Robinson DL
    J Neurochem; 2002 Aug; 82(4):721-35. PubMed ID: 12358778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ghrelin and food reward: the story of potential underlying substrates.
    Skibicka KP; Dickson SL
    Peptides; 2011 Nov; 32(11):2265-73. PubMed ID: 21621573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system.
    Sagheddu C; Melis M
    CNS Neurol Disord Drug Targets; 2015; 14(4):502-17. PubMed ID: 25714966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychological Processes in Chronic Pain: Influences of Reward and Fear Learning as Key Mechanisms - Behavioral Evidence, Neural Circuits, and Maladaptive Changes.
    Nees F; Becker S
    Neuroscience; 2018 Sep; 387():72-84. PubMed ID: 28890049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocannabinoids: Effectors of glucocorticoid signaling.
    Balsevich G; Petrie GN; Hill MN
    Front Neuroendocrinol; 2017 Oct; 47():86-108. PubMed ID: 28739508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.